Skip to main content

Immunovant, Inc.

IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764013

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

13F holders, Q1 2024

Institutional positions in Immunovant, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
209
−18 vs. Q4 2023
Shares held
70.4M
+2.04M (+3.0%) vs. Q4 2023
Total value
$2.27B
−$606.7M (−21.1%) vs. Q4 2023
New holders
28
83 more added
Sold out
46
78 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IMVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 209 institutions
Q1 2021: 120 institutionsQ2 2021: 110 institutionsQ3 2021: 119 institutionsQ4 2021: 118 institutionsQ1 2022: 112 institutionsQ2 2022: 94 institutionsQ3 2022: 112 institutionsQ4 2022: 133 institutionsQ1 2023: 142 institutionsQ2 2023: 147 institutionsQ3 2023: 181 institutionsQ4 2023: 228 institutionsQ1 2024: 209 institutionsQ2 2024: 197 institutionsQ3 2024: 182 institutionsQ4 2024: 187 institutionsQ1 2025: 194 institutionsQ2 2025: 169 institutionsQ3 2025: 186 institutionsQ4 2025: 197 institutionsQ1 2026: 216 institutionsQ2 2026: 226 institutions
Value heldQ1 2024: $2.27B
Q1 2021: $654.3MQ2 2021: $407.5MQ3 2021: $293.6MQ4 2021: $322.4MQ1 2022: $218.6MQ2 2022: $156.5MQ3 2022: $238.1MQ4 2022: $1.00BQ1 2023: $903.7MQ2 2023: $1.05BQ3 2023: $2.57BQ4 2023: $2.88BQ1 2024: $2.27BQ2 2024: $1.97BQ3 2024: $2.26BQ4 2024: $1.98BQ1 2025: $1.62BQ2 2025: $1.54BQ3 2025: $1.53BQ4 2025: $2.76BQ1 2026: $2.75BQ2 2026: $4.25B
Institutions holding IMVT and their total value by quarter
QuarterHoldersValue
Q2 2026226$4.25B
Q1 2026216$2.75B
Q4 2025197$2.76B
Q3 2025186$1.53B
Q2 2025169$1.54B
Q1 2025194$1.62B
Q4 2024187$1.98B
Q3 2024182$2.26B
Q2 2024197$1.97B
Q1 2024209$2.27B
Q4 2023228$2.88B
Q3 2023181$2.57B
Q2 2023147$1.05B
Q1 2023142$903.7M
Q4 2022133$1.00B
Q3 2022112$238.1M
Q2 202294$156.5M
Q1 2022112$218.6M
Q4 2021118$322.4M
Q3 2021119$293.6M
Q2 2021110$407.5M
Q1 2021120$654.3M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Immunovant, Inc.; share changes are against Q4 2023.

Institutions holding IMVT in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Private Trust Co NA112$3.62K0.00%−81−42.0%Reduced
GAMMA Investing LLC110$3.55K0.00%+31+39.2%Added
Principal Securities, Inc.70$2.26K0.00%−31−30.7%Reduced
CWM, LLC53$2.00K0.00%+51+2,550.0%Added
Lindbrook Capital, LLC55$1.78K0.00%−164−74.9%Reduced
Nelson, Van Denburg & Campbell Wealth Management Group, LLC11$3550.00%+11New
Rothschild Investment LLC5$1620.00%+5New
EverSource Wealth Advisors, LLC3$820.00%+3New
Farther Finance Advisors, LLC2$630.00%−2−50.0%Reduced
Cormorant Asset Management, LP0$00.00%−1,165,000−100.0%Sold out
Farallon Capital Management, L.L.C.0$00.00%−341,000−100.0%Sold out
Jennison Associates LLC0$00.00%−313,205−100.0%Sold out
BVF Inc0$00.00%−300,000−100.0%Sold out
Sofinnova Investments, Inc.0$00.00%−222,553−100.0%Sold out
Superstring Capital Management LP0$00.00%−203,592−100.0%Sold out
Soros Fund Management LLCSuperinvestorSoros Fund Management0$00.00%−140,000−100.0%Sold out
HighVista Strategies LLC0$00.00%−121,287−100.0%Sold out
HRT Financial LP0$00.00%−92,731−100.0%Sold out
Lighthouse Investment Partners, LLC0$00.00%−86,180−100.0%Sold out
Altium Capital Management LP0$00.00%−80,000−100.0%Sold out
Weiss Multi-Strategy Advisers LLC0$00.00%−75,631−100.0%Sold out
Cowen and Company, LLC0$00.00%−69,410−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−61,820−100.0%Sold out
Neuberger Berman Group LLC0$00.00%−43,720−100.0%Sold out
Healthcare of Ontario Pension Plan Trust Fund0$00.00%−33,000−100.0%Sold out
Velan Capital Investment Management LP0$00.00%−27,500−100.0%Sold out
New York Life Investment Management LLC0$00.00%−22,438−100.0%Sold out
Jefferies Financial Group Inc.0$00.00%−21,574−100.0%Sold out
Walleye Trading LLC0$00.00%−20,390−100.0%Sold out
Silverarc Capital Management, LLC0$00.00%−20,000−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−19,400−100.0%Sold out
Natixis0$00.00%−16,900−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−14,534−100.0%Sold out
GTS Securities LLC0$00.00%−14,286−100.0%Sold out
Jupiter Asset Management Ltd0$00.00%−11,165−100.0%Sold out
Captrust Financial Advisors0$00.00%−10,792−100.0%Sold out
Maven Securities LTD0$00.00%−10,000−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−9,783−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−9,241−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−8,760−100.0%Sold out
Engineers Gate Manager LP0$00.00%−8,451−100.0%Sold out
Point72 Middle East FZE0$00.00%−8,272−100.0%Sold out
JFG Wealth Management, LLC0$00.00%−7,000−100.0%Sold out
Bailard, Inc.0$00.00%−6,300−100.0%Sold out
Pictet & Cie (Europe) SA0$00.00%−5,512−100.0%Sold out
Atom Investors LP0$00.00%−5,431−100.0%Sold out
Torno Capital, LLC0$00.00%−5,000−100.0%Sold out
Federated Hermes, Inc.0$00.00%−2,979−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−1,104−100.0%Sold out
Headlands Technologies LLC0$00.00%−636−100.0%Sold out
Itau Unibanco Holding S.A.0$00.00%−65−100.0%Sold out
Fortitude Family Office, LLC0$00.00%−21−100.0%Sold out
Bell Investment Advisors, Inc0$00.00%−15−100.0%Sold out
Tfo-TDC, LLC0$00.00%−9−100.0%Sold out
Gradient Investments LLC0$00.00%−2−100.0%Sold out
Putnam Investments LLC––––Not filed